Skin necrosis: An uncommon side effect of warfarin therapy
Öz
Warfarin is commonly used in the treatment and prevention of thromboembolic events. However, it is known to undesirably cause hypercoagulable conditions, including warfarin-induced skin necrosis (WISN). This report describes a 70-year-old man presented with an extensive WISN while an inpatient for treatment of a left deep femoral vein thrombosis. He had a background of colon adenocarcinoma and multiple metastatic foci in the liver.
Anahtar Kelimeler
Kaynakça
- Nazarian RM, Van Cott EM, Zembowicz A, Duncan LM. Warfarin-induced skin necrosis. J Am Acad Dermatol 2009;61(2):325-32.
- Kakagia DD, Papanas N, Karadimas E, Polychronidis A. Warfarin-induced skin necrosis. Ann Dermatol 2014;26(1):96-8.
- Menon N, Sarode R, Zia A. Rivaroxaban dose adjustment using thrombin generation in severe congenital protein C deficiency and warfarin-induced skin necrosis. Blood Adv 2018;2(2):142-5.
- Chan YC, Valenti D, Mansfield AO, Stansby G. Warfarin induced skin necrosis. Br J Surg 2000;87(3):266-272.
- Hasegawa H. Clinical assessment of warfarin therapy in patients with maintenance dialysis-clinical efficacy, risks and development of calciphylaxis. Ann Vasc Dis 2017;10(3):170-7.
- Hamada T, Miyake T, Otsuka M, Iwatsuki K. Warfarin-induced skin necrosis accompanied by aggravation of vasculitis in a patient with cutaneous arteritis. Int J Dermatol 2017;56(7):779-81.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Sağlık Kurumları Yönetimi
Bölüm
Olgu Sunumu
Yayımlanma Tarihi
28 Haziran 2019
Gönderilme Tarihi
31 Ocak 2018
Kabul Tarihi
9 Nisan 2018
Yayımlandığı Sayı
Yıl 2019 Cilt: 58 Sayı: 2